ASCO applauds Congress for working across party lines to raise the minimum age for purchasing tobacco products to 21 and for continuing its commitment to investing in our nation’s biomedical research infrastructure.
Vivek Subbiah: ASCO 2025 Annual meeting is shaping up to be incredible / American Society of Clinical Oncology, ASCO, ASCO 2025, cancer, OncoDaily, Oncology,
This prospective multicenter study including individuals with hematuria evaluates the performance of a urinary DNA methylation test in identifying patients with high-grade or invasive bladder…
This cohort study examines the response and survival rates associated with ipilimumab-nivolumab therapy in patients with progressive melanoma brain metastases after anti–programmed cell death 1…
5 articles suggested by Vivek Subbiah / A. Ari Hakimi, A. Ducassou, A. Italiano, A. Michot, Abhinav Pandey, Abraham S. Singh, Aby Abraham, Aleksandra
Nature – The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.
Radiotherapy is essential for locoregional control in resectable soft-tissue sarcoma (STS) and remains a key strategy for unresectable STS. PARP inhibitors, such as olaparib, may…
Nature Medicine – Using multiple datasets from real-world evidence and completed trials, a machine learning model using routine blood and clinical data is shown to…
Abstract. Approximately 10% of children with cancer harbor a mutation in a predisposition gene. In children with the kidney cancer Wilms tumor, the prevalence is…
Atezolizumab plus bevacizumab is the standard of care for patients with advanced hepatocellular carcinoma. Building on the impressive results of IMBrave150,1 the phase 1b–2 MORPHEUS-Liver…
This review examines the incidence of second primary cancers after treatment with chimeric antigen receptor T cells in patients with hematologic cancers.
